Fungal endophthalmitis is subsequent to endogenous or exogenous infection and represents an important complication of ocular surgery which may lead to significant visual loss and blindness. The prognosis is poor because of delayed diagnosis and limited availability of effective antifungal drugs with good ocular penetration. Furthermore, the critical issue in diagnosing fungal infection of the eye is microbiological identification of the etiologic agent in clinical samples. Aspergillus is among the most frequent isolated organisms in fungal endophthalmitis. Early diagnosis is essential to prevent severe complications and blindness. Treatments include local, systemic and surgical therapeutic strategies. The purpose of the present review is the analysis of the current procedures adopted to promptly diagnose and treat Aspergillus endophthalmitis.
Introduction
Ocular fungal infections represent a significant cause of loss of vision due to the involvement of different segments of the eye: cornea, orbit, eyelid, lacrimal apparatus, conjunctiva, sclera and internal structures in case of endophthalmitis. 1 Exogenous endophthalmitis may be consequent to postoperative or posttraumatic complications, whereas endogenous endophthalmitis derives from the hematogenous spread of pathogens into the eye and affects immunodepressed patients. 2 The incidence of endophthalmitis ranges from 0.03% to 1.3% following cataract surgery and can be as high as 30% to 40% following open globe injuries. 3 Fungal endophthalmitis accounts for 8.6% to 18.6% of culture-positive cases and has increased over the last 20 years, probably because of a larger amount of immunodepressed individuals. [4] [5] [6] Aspergillus accounts for 56% to 74% of all cases of fungal endophthalmitis after cataract surgery. 4, 7 The rate varies between 4% and 14% of fungal endophthalmitis following bulbar trauma. 8 Aspergillus is the second most common cause of endogenous fungal endophthalmitis after Candida; the infection involves most frequently immunocompromised patients affected by Human Immunodeficiency Virus (HIV), malignancy, diabetes mellitus, or in therapy with immunodepressive medications. 9 Other associations include solid organ transplantation, drug use, lung disease and renal insufficiency. However, immunocompetent individuals may also be affected by Aspergillus endophthalmitis with no risk factors. 10 Aspergillus causes reduction of visual capacity because of early macular involvement, retinal necrosis and choroidal damage. 11 This severe and irreversible damage has to be prevented with an early diagnosis.
A PubMed search was performed using the search terms "Aspergillus, endophthalmitis, fungal infection, cataract surgery, ocular mycoses" and a full systematic review of the literature was conducted up until August 2019 to analyze current strategy to diagnose and treat Aspergillus endophthalmitis and discuss both pharmacological and surgical approach used for the management.
Ocular Mycoses: The Role of Aspergillus
Aspergillus is a harmless saprophyte fungus, and it is present everywhere. 12 Infections due to Aspergillus commonly involve the lungs and the paranasal sinuses. 13 Furthermore, infections of the tear ducts are very rare, with prolonged local therapy including antibiotics and corticosteroids being a very high-risk factor. 14 Fungal etiology is responsible for about 5% of cases of lacrimal sac infection; the main pathogens include Aspergillus and Candida, but cases caused by Rhizopus have been reported as well. 15 Fungal conjunctivitis is usually secondary to inflammation of the cornea, lacrimal sac and tear ducts. The etiologic agents include Candida, Aspergillus, Sporotrichum, Blastomyces, Coccidioides, Malassezia and dermatophytes that cause acute inflammation of the conjunctiva with mucopurulent discharge. 1 Fungal scleral involvement has been reported after traumas caused by Aspergillus or Sporothrix schenckii. 16 Fungal infection of the cornea manifests as purulent, ulcerative disease and accounts for 6% to 53% of cases of ulcerative keratitis. 17 The most frequent risk factors include trauma, long-term use of corticosteroids and antibiotics, systemic diseases, especially diabetes, pre-existing eye surface infections and contact lenses. 17, 18 Fusarium and Aspergillus are the most frequent fungal agents affecting the cornea, particularly in young healthy men who work in the open air, such as farmers. Trauma factors include particles of mud or dust, tree branches, metal particles, plant-derived organic matter and the use of nylon-line brushcutters. 1 Rosa et al stated that injuries of the eye favored infections caused by Fusarium (70%), Curvularia (11%) and Aspergillus (5%), whereas diabetes predisposed to infections caused by Fusarium (67%) and Candida (13%). 19 Chronic use of topical ophthalmic drugs may lead to infections caused by Candida (44%) and Fusarium (38%); in contrast, in patients treated with topical corticosteroids, the most frequently isolated species are Candida, Aspergillus, Acremonium and Curvularia (22% each). 19 Bloodstream infections are a common cause of inflammation of the uveal tract. The risk factors include catheters, Acquired Immune Deficiency Syndrome (AIDS), neutropenia, and immunosuppressive therapy. Most cases are caused by Candida, but other fungal pathogens are also involved: Cryptococcus, Sporothrix schenckii and Blastomyces. Multifocal uveitis and severe vitritis have been reported after fungal infections, as well as endophthalmitis. 20 Endogenous infections may be due to complications of fungal inflammations located in other organs, such as the heart valves, the central nervous system and the genitourinary tract. 21, 22 Several cases of aspergillosis following aortic valve implantation have been described, presenting with fever of unknown origin or late embolic events, 23 even if Rocco et al reported an unusual case of acute Aspergillus endophthalmitis from an aortic embolization with no systemic infectious symptoms. 24 The mechanism of this infection was unclear, but probably the exposure likely occurred intra-operatively, through contaminated ventilation systems. 24 Mortality range for Aspergillus aortitis varies from 93-100%. [23] [24] [25] [26] Clinicians must have a high index of suspicion in order to facilitate timely diagnosis and immediate treatment. Trans-esophageal echocardiography is essential in diagnosing the pseudoaneurysm, but computed tomography scan angiography of the chest is considered the gold standard for diagnosis. [23] [24] [25] [26] The serum biomarkers, such as the galactomannan (GM) enzyme immunoassay (EIA), in the diagnosis of invasive Aspergillosis, are still a discussion topic.
Endogenous Aspergillus endophthalmitis has been reported by Al Qahtani et al secondary to fungal endocarditis in an immunocompromised patient affected by Wegener' granulomatosis. 27 Prakash et al described a case of endophthalmitis due to Aspergillus fumigatus in a 40-yearold man with angioimmunoblastic T-cell lymphoma, who finally died for severe fungal sepsis. 28 While Candidosis affects primarily people with weakened immune system, treated for sepsis with broadspectrum antibiotics or nourished parenterally, or after organ transplantation, Aspergillus and Fusarium are most commonly involved in endogenous infections in drug addicts or people undergoing long-term corticosteroid therapy. 21, 22 Exogenous endophthalmitis occurs after trauma, intraocular surgery or as a complication of corneal inflammation, and Aspergillus infection has also been reported as a causal agent. 29 induced Aspergillus endophthalmitis complicated with necrotizing scleritis 30 Gruener et al presented a case of necrotizing scleritis following Aspergillus fumigates endophthalmitis in a diabetic man, after pars plana vitrectomy for retinal detachment, so that the Authors suggest to suspect fungal infection after ocular surgery in the differential diagnosis, particularly in case of inadequate response to intravitreal antibiotics. 31 Fungal infections of the eye socket are mostly a consequence of orbital inflammation in the surrounding tissues, such as the paranasal sinuses, skin and nasopharynx. Infections occur most frequently in immunocompromised patients. The etiologic factors may include Mucor, Rhizopus, Absidia, Aspergillus, Blastomyces and Sporothrix. 32 Prompt diagnosis and effective treatment are extremely important for the future prognosis.
Diagnostics
Patients affected by Aspergillus ocular infection may suffer from pain, burning and foreign body sensation, tearing, hyperemia and blurred vision. A short flowchart of diagnostic approach in case of suspected ocular fungal infection is shown in Figure 1 .
The principal effects of ocular Aspergillus infection are summarized in Box 1.
Slit Lamp Examination
Slit lamp examination shows thickened eyelid margins and conjunctival injection, while corneal involvement often leads to grayish-white corneal stromal infiltration with fluffy margins located centrally and central corneal epithelial defects ( Figure 2A ). Corneal ulcer and melting with hypopyon can also be found, as well as corneal satellite lesions, flare and cells in the anterior chamber ( Figure 2B -D).
Fundus Examination
When the infection spreads in the posterior segment, dense vitreous haze, vitritis or vitreous abscess may cause severe proliferative vitreoretinopathy, subretinal exudates and retinal detachment.
Fundus examination often shows fluffy white preretinal lesions with creamy white deep retinal lesions and intraretinal hemorrhages, large wedge-shaped quadrants of pigmented chorioretinal atrophy and scarring (Figures 3 and 4) .
Fluorescein Angiography
Fluorescein angiography shows hyperfluorescence of the preretinal granuloma and the surrounding deep retinal lesions, and staining of the chorioretinal scars, focal vasculitis and leakage from the involved vessels.
Ultrasound Examination
Ultrasound examination is mandatory in case of suspected endophthalmitis and when the fundus is not explorable. Ultrasounds show dense opacities in the vitreous chamber for vitritis, thickening of the retinochoroidal layer due to subretinal exudative lesions, pre and intraretinal hemorrhages, preretinal layering of exudates that lead to epiretinal membranes and retinal detachment.
Cultural Investigations
The lacks of standardized serological tests, as well as the frequent absence of positive blood culture samples, make diagnosis very difficult. Vitreous culture, instead, shows a high percentage of positive result and may help in establishing diagnosis. 33 The prognosis of fungal endophthalmitis depends upon the virulence of the organism, the timing of intervention, and the extent of intraocular involvement, but visual outcomes are often limited. 34 Intraocular surgery, such as cataract surgery, may favor inoculation of Aspergillus into the eye, resulting in an acute-onset postoperative endophthalmitis, and leading to a delayed diagnosis and management. Haddock et al described two patients who presented endophthalmitis within the first two weeks after cataract surgery, suggesting the possibility of infection at the time of surgery or in the early postoperative period. 35 Aspergillus is ubiquitary. It has been isolated from soil and decaying organic matter. 36 Aspergillus fumigatus and Aspergillus flavus are the most common species implicated in intraocular infection. Other species detected in ophthalmic disease include Aspergillus niger, Aspergillus terreus, Aspergillus ustus, Aspergillus glaucus, Aspergillus versicolor and Aspergillus conicus. [37] [38] [39] [40] As suggested by Gao et al, fungal endophthalmitis may occur as a consequence of fungal keratitis. 41 Xie et al reported fungal keratitis are due primarily to Fusarium infection; Aspergillus ranked second among all pathogens. In the culture-positive samples, cornea accounted for over half. 42 Corneal scraping or corneal buttons might be used for cultural analysis, even if it is not reality to submit all keratitis corneas, hypopyon, or vitreous abscess samples for culture. Positive outcomes of corneal cultural samples are probably due to the spread of infection from the corneal tissue, so that they should be obtained before starting antifungal treatment. 41 Although blood cultures, serological tests and pulmonary radiography may be negative in case od Aspergillus endophthalmitis, cultures of pars plana vitrectomy specimens and examination of Gram-or Giemsa-stained smears should be considered as diagnostic tests for deep retinitis and/or choroiditis. 11, 43, 44 When scleral necrosis and perforation occur, confirmed diagnosis is possible after enucleation of the eye globe. 43 Microbiological identification is essential for diagnosing fungal infections of the eye; samples may include swabs from the conjunctival sac, corneal scraping, vitreous or other material obtained during biopsy. 1 Tissue material such as corneal scrapings can be lightened with dimethyl sulfoxide (DMSO), which allows better visualization of the fungus. In the culture methods, the samples are inoculated on Sabouraud medium and incubated at 37°C and 27°C for 7-10 days. The plates are examined daily followed by macroscopic and microscopic evaluation of the colonies. 1 Other diagnostic methods include the detection of specific antigens, such as the galactomannan antigen of Aspergillus. 1
Molecular Examinations
Molecular techniques, like fluorescence in situ hybridization (FISH), polymerase chain reaction (PCR) and reverse transcription-PCR (RT-PCR) for the detection of genetic material of the fungi in clinical specimens can also be used. PCR plays an important role since multiplex testing needs a small volume of fluid to be performed. Sterility of intraocular environment makes ocular fluids ideal for PCR analysis, although contamination by commensal microorganisms is still a potential confounding factor. 40 
Histopathology and Further Investigations
Histopathological examinations of tissue samples are always of great value, but not always possible. Rate of positivity of these tests is not specified in Literature.
High-resolution computed tomography (HRCT) and magnetic resonance (MR) imaging can also be very useful. 1 In selected cases, when diagnostic pars plana vitrectomy and vitreous cultures are negative and ocular or systemic progression of the disease is confirmed, despite intravitreal or systemic treatment, retinochoroidal biopsy has proven to play a role in diagnosing fungal endophthalmitis and helping isolate the pathogen involved. Biopsy of chorioretinal tissue has to be reserved for selected cases because it carries significant risks of choroidal bleeding, vitreous loss and retinal detachment. 45 
Treatment

Antifungal Therapy
Intravitreal and/or systemic amphotericin B is commonly used to treat Aspergillus endophthalmitis, although the intraocular form may be toxic to retina. 46 Intravitreal amphotericin B (5mg/0.1 mL) has been safely used. Intravitreal dexamethasone is administered to reduce intraocular inflammation, although the efficacy has not been tested in controlled, masked studies. 9, 36, 47 Oral prednisone 1mg/kg/body weight should be used in tapering doses. Steroids should be administered in case of severe inflammation but with caution and close controls. Pars plana vitrectomy is necessary to confirm diagnosis and start correct treatment. Several species of Aspergillus can be highly resistant to amphotericin B and side effects often limit its systemic use. Alternative systemic antifungals include caspofungin and voriconazole. This last has good intraocular penetration allowing systemic treatment alone; when used intravitreally, it may be safer than amphotericin B. 46 Voriconazole is a second-generation synthetic derivative of fluconazole with broad spectrum of activity. 48 Intravitreal dose of voriconazole up to 100 microgram/ mL is considered safe for the retina. 49 Voriconazole should be considered as a first-line intravitreal agent to treat fungal endophthalmitis as well as amphotericin B. 49 Itraconazole shows low MIC for many species of Aspergillosis, and selected reports reported a favorable response for the treatment of invasive aspergillosis. 50, 51 The vitreous penetration of itraconazole is better than amphotericin B but remains only a fraction of the serum level. 52 
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The duration of systemic antifungal therapy is variable but drugs should be administered for at least 1 month. The frequency of intravitreal injection changes depending on the clinical course, but published data report injections every 48 hrs on average. The appropriate treatment should be chosen together with an infectivologist, especially in case of immunocompromised patients.
Surgery
Common symptoms associated with fungal endophthalmitis are decreased vision, pain, hypopyon, blurring of the iris details. Initially, the infection involves the anterior segment, but later spreads to involve into the eye. Retinal detachment, cyclic membrane formation, and contraction of fibrous tissue may be consequent to inflammation due to Aspergillus. 35 It is not always possible to identify fungal organisms in histological samples after pars plana vitrectomy with placement of silicone oil performed to repair retinal detachment, after several intravitreal injections. 35 Previous reports suggested that using silicone oil could prevent the growth of microbes, including bacterial and fungal isolates. 54 Furthermore, it helps reduce rates of complications, like retinal detachments or hypotony. 55 Nevertheless, it was recently assessed that silicone oil might play a weaker role in antifungal therapy; 56 furthermore, nontoxic concentrations of intravitreal drugs could create toxicity in a silicone oil-filled eye. 57 Gao et al also did not recommend silicone oil tamponade in uncontrolled endophthalmitis eye. 41 Vinekar et al presented a series of 6 eyes affected by fungal endophthalmitis (Aspergillus and Candida) following cataract surgery with a mean of 4.16 recurrences. 58 The median interval after cataract surgery at presentation was 7 weeks. The eyes showed persistent infection despite a mean of two vitrectomies, systemic and intraocular use of antifungal agents, even newer agents like voriconazole. Following a final vitrectomy and IOL explantation with careful removal of the capsule, they were able to prevent further recurrences during a mean follow-up period of 36.5 months. The Authors suggested that the fungal spores are sequestered over the IOL surface and in the capsular bag and are responsible for the multiple recurrences. 58 There is evidence to suggest that fungal filaments survive on the surface of IOL 59 and in the capsular bag, 60 even if prospective long-term studies in larger series are necessary to establish if IOL removal should be a standard of care.
Performing vitrectomy in case of fungal endophthalmitis is frequently discussed. Gao et al supported a prompt vitrectomy in case of a large vitreous abscess or lack of response to intravitreal injections. 41 When complete vitrectomy is not allowed for unclear media, a core vitrectomy is indicated. Aggressive vitrectomy may increase the risk of retinal damage. A second vitrectomy should be performed when the media would get clearer and the infection controlled. 41 On the other hand, surgical approach to fungal endophthalmitis following keratitis is controversial. Gao et al reported a penetrating keratoplasty (PKP) ratio of 81.5% in their series of patients affected by fungal endophthalmitis secondary to keratitis. They encountered two types of corneal opacity: the first was a large area of opacity resulting from corneal ulcer, melting or endothelial plaque; surgical treatment is always required in this case. The other type was a small scope of infiltration after injury with chestnut thorns. The Authors performed PKP after a mean time of 4.5 days from the beginning of the antifungal therapy, and PKP allowed to clear original infection focus for clinical examination and treatment of intraocular infection. 41 PKP should be performed after one week treatment period in fungal keratitis, as reported in Literature. 61, 62 However, when combined with endophthalmitis, PKP should be performed earlier (PKP à chaud) ( Figure 2D ).
Fungal endophthalmitis may also occur after glaucoma drainage devices (GDD) for filtering surgery. 33 Removal of GDD following endophthalmitis is still a discussion topic. If removal of GDD at the time of treatment could promote improvement in final visual acuity or not is unclear; some studies recommended the removal of GDD as it serves as reservoir of infection. 33, 63 Another relevant factor is represented by the state of latency of the tear ducts. In chronic dacryocystitis, superinfection of Aspergillus and Candida is possible, so that dacryocystorhinostomy (DCR) should be performed in case of epiphora, lacrimal sac mucocele and obstruction of the passage to prevent the risk of post-operative endophthalmitis caused by pathogens retained within the lacrimal system. 43 
Combined Antifungal Treatments
We discussed about medical and/or surgical treatment to manage Aspergillus endophthalmitis, but what about the possibility to combine antifungal drugs? The in vivo efficacy of a combined antifungal therapy in life-threatening systemic fungal infections has been proven, 64 and good visual outcome has been reported after combination of intravitreal antifungals. 65 Different types of drug interactions have been studied in vitro: synergism, indifference, or antagonism between these agents. 66 Amphotericin B, a polyene, is firstly used for systemic mycosis and endophthalmitis caused by filamentous fungi. 67 It acts by binding the surface sterols in the cell membrane of the fungi; this results in formation of pores and altered permeability. 68 Voriconazole, an azole, acts chiefly by depleting ergosterol, the chief bioregulator of membrane integrity. 67 As suggested by Steinbach et al azoles may inactivate amphotericin B which is adsorbed into the fungal cell surface, so that amphotericin B binding to fungal cell membrane is inhibited. 69 On the contrary, amphotericin B when combined with lipophilic triazoles, like itraconazole, was found to be deleterious or ineffective, while amphotericin B when combined with voriconazole was found to be beneficial in a few but not all experimental studies. 64, 66, 69 Mithal et al proposed a combination therapy with intravitreal amphotericin B and voriconazole for the treatment of filamentous endophthalmitis due to Aspergillus terreus, Aspergillus flavus and Fusarium solani. They also suggested to study the effect of combining these two drugs in vitro with regard to possible synergism and correlate it with the in vivo response. 70 
Conclusion
Aspergillus endophthalmitis represents a severe challenge for ophthalmologists. Early diagnosis is necessary to preserve visual function 71 and eye globe anatomy, but often difficult. Ocular prognosis is variable and not infrequently necessitating enucleation of the painful blind eye. Multidisciplinary approach may be essential for the diagnosis, for the management and treatment: it is critical for the ophthalmologist to work with infectious disease specialists, pharmacists, and any specialist can be involved particularly in case of systemic disease or unknown origin focus of infection. If the general condition of the patient permits a surgical procedure, a combined treatment of prompt vitrectomy and intravitreal antifungal agent injection may improve visual outcomes. Repeated injections and repeated vitrectomy are possible as well as the use of a combination of antifungal drugs. Removal of implanted IOL and PKP à chaud may be necessary to prevent recurrence and eliminate fungal growth colonies. Despite the efficacy of local and or systemic therapy, resistances to antifungal medicaments are more and more frequent and no standardized treatment protocols are still available.
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